Literature DB >> 6225644

Regional cardioplegia and cardioprotection during transluminal angioplasty, which role for nifedipine?

P W Serruys, M van den Brand, R W Brower, P G Hugenholtz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6225644     DOI： 10.1093/eurheartj/4.suppl_c.115

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  13 in total

1.  Protective effects of pretreatment with intracoronary nifedipine on myocardial ischemia and dysfunction.

Authors:  I Amende; G Herrmann; R Simon; W P Hood; P Wenzlaff; P R Lichtlen
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

Review 2.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

Review 3.  Role of calcium channel blockers in reducing acute ischaemia and preventing restenosis in PTCA.

Authors:  A Vahanian; B Lung
Journal:  Drugs       Date:  1996       Impact factor: 9.546

4.  Outcome of early surgery after coronary angioplasty.

Authors:  M S Norell; J Lyons; C Layton; R Balcon
Journal:  Br Heart J       Date:  1986-03

5.  The negative inotropic and chronotropic effects of intravenous R 56865 during percutaneous transluminal coronary angioplasty.

Authors:  A J Pijl; H B Van Wezel; J J Koolen; J J Piek; K Koch; A Swaan; G K David; C A Visser; P A Van Zwieten
Journal:  Br J Clin Pharmacol       Date:  1995-05       Impact factor: 4.335

6.  Similar antiischemic effects of intracoronary atenolol and nifedipine during brief coronary occlusions in humans.

Authors:  S Ghio; S De Servi; L Angoli; E Bramucci; E Eleuteri; S Raffaghello; G Specchia
Journal:  Cardiovasc Drugs Ther       Date:  1992-06       Impact factor: 3.727

7.  Effect of gallopamil on myocardial ischaemia during percutaneous transluminal coronary angioplasty.

Authors:  B Rauch; J Neumann; G Richardt; R Kranzhöfer; R Barth; R Zimmermann; H P Koch; H Tillmanns; A Schömig
Journal:  Drugs       Date:  1991       Impact factor: 9.546

Review 8.  Protective effects of calcium antagonists against ischaemia and reperfusion damage.

Authors:  R Ferrari; O Visioli
Journal:  Drugs       Date:  1991       Impact factor: 9.546

9.  Antiischemic effect of intracoronary diltiazem on myocardial ischemia during PTCA.

Authors:  K Saito; H Nonogi; Y Goto; A Itoh; S Daikoku; S Miyazaki; K Haze
Journal:  Heart Vessels       Date:  1996       Impact factor: 2.037

10.  Predictive value of early maximal exercise test and thallium scintigraphy after successful percutaneous transluminal coronary angioplasty.

Authors:  W Wijns; P W Serruys; M L Simoons; M van den Brand; P J de Feijter; J H Reiber; P G Hugenholtz
Journal:  Br Heart J       Date:  1985-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.